Yu spayna fil lɛk se i go lɔs in trɛnk? Lɛ wi tɔk bɔt Transvas Maylaytis (TM)!

Yu dɔn ɛva tink bɔt wan sik we yu nɔ ebul fɔ kɔntrol yu leg dɛn wantɛm wantɛm, yu kin fil lɛk se sɔm pat dɛn na yu bɔdi nɔ de wok fayn, ɔ i nɔ kin izi fɔ yu fɔ kɔntrol yu urine ɛn stɔl? Pan ɔl we dɛn tin ya kin mek wi fred smɔl, sɔntɛnde dɛn sik ya kin apin bikɔs ɔf wan inflamɛns na wi spɛshal kɔd , dat na di nɛv fayba dɛn we de rɔn tru di spayna. Dat na di kɔndishɔn we wi go tɔk bɔt tide, we dɛn kɔl Transvas Maylaytis (TM) . Dis na wan kayn nyurolɔjik kɔndishɔn we nɔ kin apin so ɔltɛm.

Wetin rili na transvas maylaytis (TM)?

Fɔ tɔk am simpul wan, transvas maylaytis (TM) na we yu spaynal kɔd , we na di men nerve fayba we de rɔn dɔŋ yu spayna, inflamɛns. Tink bɔt am dis we: i kin kɛr mɛsej dɛn frɔm yu bren to di ɔda pat dɛn na yu bɔdi. I tan lɛk se na tɛlifon kebul.

dis inflameshn de mek di protεktiv kכva we de rawnd di nεv sεl dεm na di spεnal kכd, we dεn kכl di myelin sheath . I tan lɛk se di plastic we de kɔba di tap pan kebul dɔn pwɛl. Wetin kin apin da tɛm de? Mesej dεm we de kכmכt na di bren nכ de pas fayn fayn wan. Dis kin mek yu gɛt prɔblɛm lɛk we yu nɔ de fil fayn, yu nɔ de fil fayn, ɛn yu nɔ de kɔntrol yu blad.

dis kכndyushכn we dεn kכl TM kin afekt di spεnal kכd εnisay along di spayna. "Myelitis" de tכk bכt inflameshn na di spεnal kכd. "Transverse" de tכk bכt di patεn we de chenj na di sεns εn fכnshכn. i kin fil lεk se dεn tay bεlt rawnd di bכdi, wit di chenj dεm we di sεns dεm de dכn dכn di bεlt.

Bɔrku tɛm, TM na wan sik wae kin kam wan tɛm ɛn afta dat i kin bɛtɛ ɔr kin de di sem.

Udat kin afɛkt mɔ pan dis kɔndishɔn, transvas maylaytis (TM)?

infakt, dis kכndyushכn we dεn kכl transvas maylaytis (TM) kin divεlכp pan εni ej, pan εnibodi. Bɔt we yu luk di data, yu go si se i kin divɛlɔp smɔl mɔ pan yɔŋ pipul dɛn we ol bitwin 10 ɛn 19 ia ɛn pan pipul dɛn we ol bitwin 30 ɛn 39. I sɔprayz fɔ no se lɛk 25% pan di wan dɛn we gɛt am na pikin dɛn. Bɔt dis nɔto sik we pɔsin kin gɛt we i kam pan jɛnɛreshɔn. So, wi nɔ nid fɔ wɔri se ɔda pipul dɛnsɛf go gɛt am jɔs bikɔs sɔmbɔdi na di famili bin gɛt am.

So aw dis tin kin apin?

Transvas maylaytis (TM) na wan sik we nɔ kin apin so ɔltɛm . Jɔs tink bɔt, ivin na kɔntri lɛk Amɛrika, na wan to et nyu kes nɔmɔ dɛn kin ripɔt pan ɛvri milyɔn ɛvri ia. Dat min se na lɛk 1400 nyu kes dɛn kin apin ɛvri ia. So i nɔto sɔntin we dɛn kin si bɔku tɛm na Sri Lanka sɛf.

Wetin na di sayn dɛm fɔ transvas maylaytis (TM)?

Transvas maylaytis (TM) simptom kin apia sɔmtɛm wantɛm wantɛm , fɔ sɔm awa ɔr dez. Na ɔda wan dɛn, di sik kin kam smɔl smɔl fɔ wan to 4 wik. Bɔt i impɔtant fɔ no se di TM sik kin wɔs kwik kwik wan .

Di sayn dɛm kin sho dɔŋ di say we yu spɛnal kɔd dɔn pwɛl. fכ egzampl, if di damej de na di midul pan yu bak, dכn yu an dεm, yu leg dεm εn yu blad/bכwel kכntrכl go afekt. Sɔntɛm yu an dɛn nɔ go afɛkt.

Bɔku tɛm, TM kin afɛkt ɔl tu di say dɛn na di bɔdi. Bɔt sɔntɛnde, na wan say nɔmɔ i kin afɛkt. Dis kayn wikɛdnɛs na wan say kin mɔs pan pipul dɛm wae gɛt sik lɛk Multiple Sclerosis (MS) .

Imajin, na di stej we TM pasmak, 50% pan di sik pipul dεm de lכs כl di muvmεnt na di tu lεg dεm. bitwin 80% ɛn 94% kin gɛt numbness ɔ unusual sensations lɛk pin ɛn nidul. Dɔn bak, na lɛk ɔlman kin gɛt sɔm kayn we fɔ mek dɛn nɔ ebul fɔ pis.

Fɔ sɔm pipul dɛm, dɛn sayn ya go smɔl ɔr nɔr de igen wit tritmɛnt, bɔt fɔ ɔda pipul dɛm, prɔblɛm kin kam fɔ ɔltɛm.

Bɔku men grup dɛn de we gɛt fɔ du wit di sik we dɛn kin si pan TM:

• Senseshɔn dɛn we nɔ kɔmɔn
• Pen
• Prɔblɛm dɛn we gɛt fɔ du wit yu bɔdi ɛn yu urinary
• Prɔblɛm dɛn we gɛt fɔ du wit di mɔsul ɛn muvmɛnt
• Prɔblɛm dɛn we kin apin we pɔsin de du mami ɛn dadi biznɛs
• Ɔda sayn dɛn we de sho se yu gɛt dis sik

Senseshɔn dɛn we nɔ kɔmɔn

dipכnt pan usay yu spεnal kכd dכn pwεl bikoz fכ TM, yu kin gεt abnכmal sεns dεm (dεn kכl am bak ``Paresthesia'' insay mεdikal tεm dεm) na sכm pat dεm na yu bכdi, lεk:

• Fɔ mek pɔsin nɔ ebul fɔ du natin
• Fɔ fil lɛk fɔ prik (Prickling) .
• Fɔ bɔn
• Hypersensitivity to tɔch ɔ tɛmpracha
• Less sensation of ɔt/kol

Pen

TM kin mek yu fil pen na sɔm pat dɛn na di bɔdi. Dis pen kin shap ɔ i kin dɔl . Sɔmtɛm dis pen kin rayt dɔŋ di an ɛn/ɔ leg, ɔ i kin fil lɛk se i de kɔmɔt na di chɛst ɛn bɛlɛ.

Stɔl ɛn urinary simptom dɛn

TM kin mek yu gɛt prɔblɛm wit yu urinary ɛn bowel lɛk:

• Banbɛlɛ
• Nɔ ɛmti di blad kɔmplit wan we yu de pis (`(Urinary retention)`)
• Prɔblɛm fɔ kɔntrol di urinary, fɔ ɛgzampul, fɔ gɛt fɔ pis bɔku tɛm (`(Urge incontinence)`)
• I nɔ ebul fɔ kɔntrol di we aw yu de pis (`(Urinary incontinence)`)

Prɔblɛm dɛn we gɛt fɔ du wit di mɔsul ɛn muvmɛnt

Pipul wae gɛt TM kin gɛt wikɛd tin na dɛn leg, we kin go bifo kwik kwik wan. If di inflamɛns dɔn afɛkt di spɛshal kɔd sɔm we , i kin afɛkt di an dɛn bak.

Yu kin si sayn dɛm lɛk dis:

• Lɔs fɔ balans na di bɔdi
• I nɔ izi fɔ waka (fɔ stɔp, fɔ drɛg yu leg) .
• Di mɔsul dɛn we de spam
• Sɔm pat pan di mɔsul dɛn nɔ kin wok fayn, sɔntɛnde i kin ivin mek i nɔ ebul fɔ waka .

Prɔblɛm dɛn we kin apin we pɔsin de du mami ɛn dadi biznɛs

Pipul wae gɛt TM kin gɛt prɔblɛm fɔ rich ɔrgazm. Apat frɔm dat, man dɛn kin gɛt prɔblɛm wit di erectile dysfunction.

Ɔda sayn dɛn we de sho se yu gɛt dis sik

Apat frɔm dat, TM kin mek yu gɛt dɛn sik ya bak:

• Fil fɔ it
• Ɛd we de at (ed we de at) .
• Fiva
• I nɔ izi fɔ blo

Wetin kin mek pɔsin gɛt transvas maylaytis (TM)?

jεnarali, di men kכz fכ transvas maylaytis (TM) na inflameshn na di spεnal kכd.

Imajin, we sɔntin we bad kam insay wi bɔdi, lɛk vayrɔs, baktri, pɔyzin kemikal, ɔ we wi gɛt injuri, wi imyun sistɛm kin wok.

di imyun sistεm de rilis inflammatory sεl dεm εn כda tin dεm (cytokines) we de mek כda inflammatory sεl dεm. dis sεl dεm na dεn de trigεr wan inflammatory rεspכns we de εp fכ fכt tin dεm lεk baktri dεm εn bigin fכ hεl wund dεm. pan ɔl we dis inflammatory rεspכns kin nid fכ bכku tεm, sכmtεm wi imyun sistεm kin atak hεlty tisu fכ nכ rizin. Ɔ, di we aw i de ansa da fɔrina tin de kin strɔng pasmak ɛn pwɛl di bɔdi in tisu dɛn.

Na dat kin apin na TM. di inflameshn de damej di maylin sεl we de rawnd di nεv sεl dεm na di spεnal kכd.

difrεn poshubul kכz dεm de fכ inflameshn we de mek i gεt TM. Dɛn kin sheb dɛn tin ya we kin mek pɔsin gɛt dis sik to sɔm men grup dɛn:

• Kes dɛm we dɛn nɔ no di rayt kɔz (`(Idiopathic)`)
• Inflameshɔn we pɔsin kin gɛt we i gɛt infekshɔn
• כtoimyun sik dεm we de afekt di כl bכdi (`(Systemic inflammatory autoimmune diseases)`)
• Sεntri nεv sεstem sik dεm (`(Sεntral nεv sεstem sik dεm)`)

Idiopatik transvas maylaytis

``(Idiopathic) TM`` na we dεn nכ kin fכnshכn nכ spεsifi k kכz. Mɔs pan di TM pasɛnt dɛn kin fɔdɔm insay dis kategori. Sayɛnsman dɛn tink se i kin apin bikɔs wi yon imyun sistɛm de riak abnɔmal ɛn pasmak agens di spɛshal kɔd, we kin mek di bɔdi inflamɛns ɛn di tisu dɛn kin pwɛl. Bɔt dɛn stil nɔ no di rayt tin, ɔ di tin we mek i du dat.

Infεkshכn dεm we kin mek yu gεt transvas maylaytis

Bɔku baktri, vayral, parasayt, ɛn fɛns infɛkshɔn dɛn de we kin mek pɔsin gɛt TM. Sɔm pan dɛn na:

• Enteroviruses (Dis na vayrɔs dɛm we rili kɔmɔn, bɔt bɔku tɛm kin mek pɔsin gɛt smɔl sik) .
• `Wɛst Nayl vayrɔs`
• Hεpi vayrus, fכ egzampl jεnital hεpi
• `HIV`
• Varicella-zoster (di vayrɔs we de mek pɔsin gɛt chukchuk ɛn hεpi) .
• `Human T-sεl lukimiya vayrus tayp 1 (HTLV-1)`
• `Zika vayrɔs`
• Nyurobɔrɛliɔsis (Lyme sik) .
• `Sɛfilis`
• `Tubkulɔs`
• Baktri infεkshכn dεm na di skin
• `Maykoplasma baktriyal nyumonia`

Bɔku tɛm, i nɔ kin izi fɔ mek dɔktɔ dɛn tɔk fɔ tru if TM na bikɔs ɔf wan vayral infɛkshɔn insɛf, ɔ na di we aw di imyun sistɛm de ansa to infɛkshɔn.

כtoimyun sik dεm we de afekt di כl bכdi, we de asai wit transvas maylaytis

Sɔm ɔtoimyun sik dɛm wae gɛt fɔ du wit TM na:

• `Ankylosing spɔndylaytis`
• `Antifosfolipid sindrom`
• `Behçet in sik`
• `Miks kכnektiv tisu sik`
• `Ryumatɔyd atraytis`
• `Sarkoidosis`
• `Sklɛrodama`
• `Sjogren in sindrom`
• `Sistemik lupus εrytematosus (SLE)`

Sεntri nεv sεstem sik dεm we kin mek yu gεt transvas maylaytis

כtoimyun sik dεm na di sεntri nεv sεstem we kin mek TM inklud:

• `Mɔltipɛl sklɛrosis (MS)`
• Nyuromaylaytis optika spɛktrum disɔda (NMOSD) - Dɛn kin kɔl dis bak Devic in sik .
• `Myelin oligodεndrכsayt glycoprotein antibodi dizכrd (MOGAD)`
• `Akyu diseminated εnεsεfalomaylaytis`

fכ sכm pipul dεm, transvas maylaytis kin bi di fכs sayn fכ wan כtoimyun sik na di sεntri nεv sεstem, lεk mכltipl sklεrosis (MS) כ nyuromaylaytis optika spεktrum dizכrd (NMOSD) .

"Partial" myelitis, we de afekt wan sayd nכmכ na di bכdi, na kכmכn pan MS.

If pɔsin we gɛt NMOSD gɛt maylaytis, i go mɔs bi se i "kɔmplit," we min se i kin mek i paralayz bad bad wan ɛn i kin mek i nɔ fil fayn na di tu say dɛm na di bɔdi. Maylaytis pan pipul dɛm wae gɛt NMOSD kin tranga ɛn nɔr kin wɛl pas pipul dɛm wae gɛt MS.

Yu tink se vaysin kin mek pɔsin gɛt transvas maylaytis (TM)?

Na smɔl tɛm nɔmɔ, pipul dɛn dɔn ripɔt se dɛn gɛt transvas maylaytis insay tu dez to tri mɔnt afta dɛn dɔn gɛt di vaysin. Sayɛnsman dɛn stil nɔ shɔ wetin mek dis kin apin, bɔt wan tiori na dat sɔm pipul dɛn imyun sistɛm kin kɔmɔt frɔm di vaysin ɛn bigin wan ɔtoimyun prɔses. Bɔt na wan impɔtant pɔynt: Dɛn dɔn sho se vaysin sef pan bɔku risach. Dis asosieshɔn wit TM kin bi coincidence ɔ wan kɔmplikeshɔn we nɔ kin apin so ɔltɛm.

Aw dɛn kin no bɔt transvas maylaytis (TM)?

If yu gɛt sɔm sayn dɛn fɔ transvas maylaytis (TM), yu dɔktɔ go rivyu yu mɛdikal istri ɛn du yu bɔdi ɛgzam.

If dɛn tɛst ya sho se prɔblɛm de wit di spɛshal kɔd, dɛn go ɔda fɔ du ɔda tɛst dɛn. Wetin mek na so i bi?

• Mek shɔ se di spɛshal kɔd nɔ afɛkt ɔda tin pas inflamɛns, fɔ ɛgzampul , spɛshal tɔŋ , hεnia disk , ɔ kɔmprɛshɔn we kɔmɔt frɔm absεs .
• kכnfכm se abnכmal inflameshn de insay di spεnal kכd.
• If i pɔsibul, fɛn ɔndastand wetin de mek dis kayn inflamɛns we nɔ kɔmɔn.

Dɔktɔ dɛn dɔn tɔk se TM de we di spɛshal sayn dɛn dɔn de fɔ sɔm dez ɛn dɛn nɔ go ebul fɔ fɛn ɔda kɔz fɔ di spɛshal kɔd prɔblɛm pan MRI (Magnetic Resonance Imaging) skan ɔ ɔda tɛst.

Us tɛst dɛn kin du fɔ no if pɔsin gɛt transvas maylaytis?

Yu dɔktɔ kin ɔda fɔ du tɛst lɛk dis fɔ no if yu gɛt TMJ ɛn di tin we mek i gɛt am:

• MRI (Magnetic Resonance Imaging) skan fɔ di wan ol spayna: MRI na tɛst we nɔ gɛt pen. I de yuz big magnet, redio wev, ɛn kɔmpyuta fɔ mek klia pikchɔ dɛn bɔt di ɔgan dɛn ɛn di tin dɛn we de insay di bɔdi. yu kin nid fכ du tu MRI skan fכ yu spayna - wan wit spεshal tin we dεn kכl gadolinium kכntrast εn wan we nכ gεt. Dis go ɛp yu dɔktɔ fɔ no difrɛns bitwin di lɛsin dɛn we de kɔmprɛs ɛn we nɔ de kɔmprɛs.
• Bren MRI skan: Yu dɔktɔ kin ɔda bak fɔ mek dɛn du MRI skan na yu bren (wit ɔ atɔl gadolinium kɔntrast) fɔ luk fɔ lɛsin dɛn na yu bren. We dɛn de du MRI na yu bren, dat kin mek yu no bɔt ɔda tin dɛn we kin mek yu gɛt dis sik, mɔ di sik we dɛn kɔl multiple sclerosis (MS) .
• Lumbar pancture (dεn kin kכl am bak spεnal tap): Insay dis prכsidכm, di dכkta kin put nidul insay yu lכw bכk εn tek wan sεmpl f כ sεribrospεnal fכluid (CSF) . CSF na di klia wata we de rawnd yu bren ɛn spɛshal kɔd. afta dat dεn de tεst di CSF sεmpl na lab fכ si if tu mכch wayt blכd sεl dεm, εlevεt IgG indeks, כ oligoklonal IgG bεnd dεm de na di CSF. dεn inflammatory mak dεm ya dεn kin si na TM.
• Blɔd tɛst: I go mɔs bi se di dɔktɔ go ɔda fɔ mek dɛn du bɔku blɔd tɛst fɔ chɛk fɔ si if pɔsin gɛt infɛkshɔn ɛn tin dɛn we gɛt fɔ du wit di imyun sistɛm we kin mek pɔsin gɛt TM.

dipכnt pan di posbul kכz fכ TM, dεn kin du כda tεst dεm. If nɔr pan dɛn tɛst ya nɔ ebul fɔ fɛn wan patikyula kɔz, dɛn kin tek am se yu gɛt idiopathic transverse myelitis.

Transvas maylaytis (TM) na in dɛn kin trit bayAw di bɔdi ?

Bɔku men gol dɛn de fɔ trit transvas maylaytis (TM):

• If i pɔsibul, trit di tin we mek yu gɛt TM (e.g., wan infɛkshɔn).
• Fɔ ridyus di inflamɛns na yu spɛshal kɔd.
• Riliv ɔ ridyus di sayn dɛm lɛk pen.
• Fɔ manej di prɔblɛm dɛn we kin apin fɔ lɔng tɛm.

We dɛn de trit TM, dɛn kin gi shɔt tɛm tritmɛnt fɔ di inflamɛns ɛn di kɔz we i gɛt, ɛn bak fɔ mɛn di kɔmplikeshɔn dɛn we kin kɔmɔt frɔm TM fɔ lɔng tɛm.

Short-tɛm tritmɛnt fɔ transvas maylaytis

di fכs layn tritmεnt fכ transvas maylaytis na intravenכs (IV) glukokortikoyd . If yu dɔktɔ sɔspɛkt TM, dɛn go bigin fɔ gi ay doz intravenɔs (IV) glukokortikoyd kwik kwik wan.

Glucocorticoids na wan kayn sterɔyd ɔmon we de insay wan klas ɔf drɔgs we dɛn kɔl kɔtikosterɔyd . Dis na pawaful drɔgs we de fɛt inflamɛns ɛn wok wit yu imyun sistɛm. insay transvas maylaytis, glukokortikoyd dεm de εp fכ ridyus inflameshn na di spεnal kכd. Yu kin nid fɔ tek dɛn mɛrɛsin ya fɔ tri to fayv dez, ɔr pas dat.

Ɔda tritmɛnt dɛn fɔ TM kin inklud:

• Plasma exchange therapy (Plasmapheresis): Dis na prosidur we de "klin" yu blɔd. Insay dis tritmɛnt, yu dɔktɔ kin pul di wata we de na yu blɔd (plasma) ɛn put plasma we pɔsin we gɛt wɛlbɔdi ɔ pɔsin we gɛt plasma in ples. dis de pul di antibodi dεm εn כda protin dεm we dεn tink se de mek di inflammatory riakshכn. Dis tritmɛnt kin ɛp pipul dɛm wae gɛt TM wae gɛt akyu sɛntral nɛvɔ sistɛm dɛmyelinating sik wae nɔr dɔn ansa to glucocorticoid tritmɛnt.
• Intravenous Immune Globulin (IVIG): Dis na tritmɛnt we dɛn mek wit antibodi dɛm. Dɛn kin gi am tru wan vein. dis tritmεnt kin biεn di antibodi dεm we dεn tink se de mek TM εn ridyus di inflammatory rεspכns na di spεnal kכd.
• Immunosuppressant drugs: Fɔ TM pasɛnt dɛn we nɔ dɔn ansa fayn to glucocorticoids, plasma exchange, ɔ IVIG tritmɛnt, dɔktɔ dɛn kin yuz drɔgs lɛk rituximab ɛn cyclophosphamide . Dɛn drɔgs ya gɛt immunosuppressive prɔpati.
• Mɛrɛsin fɔ mɛn ɔda sayn dɛm: Yu dɔktɔ kin gi yu ɔda mɛrɛsin fɔ mɛn di sayn dɛm lɛk pen, mɔsul dɛm we de spam, prɔblɛm wit yu urinary, ɔ pwɛl hat .

Lכng tεm mεnejmεnt fכ transvas maylaytis

Afta yu dɔn gɛt tritmɛnt fɔ wan akyu ɛpisod fɔ transvas maylaytis (TM), yu go nid rihabilitetiv kia fɔ mek yu ebul fɔ wok fayn ɛn fɔ mek yu nɔ gɛt sɛkɔndari kɔmplikeshɔn dɛn we kin apin bikɔs ɔf TM.

Pan ɔl we rihabiliteshɔn nɔ kin ebul fɔ rivɛns di bɔdi damej we TM kin mek, i kin ɛp pipul dɛn we gɛt siriɔs paralayz fɔ bi indipɛndɛnt as dɛn ebul ɛn liv gud kwaliti layf as dɛn ebul.

Lכng tεm mεnejmεnt fכ transvas maylaytis kin inklud:

• Urinary function management: Pipul wae gɛt TM kin gɛt prɔblɛm wit dɛn urinary. Sɔlv dɛn na fɔ mek yu nɔ gɛt wata na yu bɔdi we yu dɔn spɛn tɛm, fɔ tek mɛrɛsin, fɔ put kɔndɔm kateshɔn, fɔ klin kateshɔn we de apin wan wan tɛm , ɛn fɔ wɛr ɔndawea we gɛt pad.
• Managing bowel function: Kɔnstipɛshɔn na kɔmɔn prɔblɛm fɔ pipul dɛn we gɛt TM. yu kin mεnεj am wit spεshal it dεm, di stratεjik yus fכ stכl sכftεna dεm εn it fayba, εn rεktal stimulashכn.
• Tritmɛnt fɔ mami ɛn dadi biznɛs: Di mɛrɛsin dɛn we dɛn kin gi fɔ mek pɔsin nɔ ebul fɔ waka na di uman in bɛlɛ na sildenafil (`sildenafil` - Viagra®) , vardenafil (`vardenafil` - Levitra®) , ɛn tadalafil (`tadalafil` - Cialis®) . Pan ɔl we dɛn drɔgs ya nɔ kin wok fayn pan uman dɛn, dɛn dɔn sho bak se dɛn kin mek dɛn du mami ɛn dadi biznɛs fayn.
• Fɔ mek yu skin nɔ krak ɛn fɔ mek yu nɔ gɛt prɛshɔn (bedsors): If yu skin de ɔnda prɛshɔn fɔ lɔng tɛm, i kin krak. Fɔ mek dis nɔ apin, yu fɔ chenj yu pozishɔn at le ɛvri 15 minit. Wilchia dɛn we gɛt pawa fɔ rek ɔ tilt-in-spɛs we kin chenj di we aw dɛn de sheb yu wet kin ɛp bak. Difrɛn kayn wilchia kusɛn dɛn de we kin mek di prɛshɔn we kin apin we yu sidɔm nɔ bɔku.
• Manejmɛnt fɔ di mɔsul dɛn we gɛt spastisiti: Di ​​we aw yu de strɛch ɛn di we aw yu de yuz bres ɛn splint kin ɛp fɔ manej ɔ fɔ mek di mɔsul dɛn nɔ gɛt spastisiti. Fɔ ɛksesaiz fɔ mek yu gɛt trɛnk ɛn fɔ mek yu mɔsul rilaks kin ɛp bak.
• Mobiliti manejmɛnt: Fizik thɛrapist kin gi ɛksesaiz fɔ mek yu ebul fɔ muv fayn fayn wan. Di tin dɛn we de ɛp yu fɔ muv lɛk ken, waka, krach, ɛn wilchia kin ɛp yu fɔ bi pɔsin we yu want fɔ du sɔntin.
• Fɔ manej di tin dɛn we dɛn kin du ɛvride: Pipul dɛn we gɛt TM kin rili at fɔ du ɛvride wok lɛk fɔ drɛs, was, klin dɛnsɛf, ɛn it. Diskushɔn wit adaptiv ikwipmɛnt ɛn ɔkupeshɔn thɛrapist kin ɛp fɔ fɛn we fɔ mek dɛn wok ya izi ɛn wok fayn.
• Pen Manejmɛnt: Na kɔmɔn tin fɔ gɛt sɔm pen afta TMJ. Dɛn kin trit di mɔsul pen wit nɔ-stɛroyd anti-inflammatory drugs (NSAID) lɛk acetaminophen (Tylenol®) , naproxen (Naprosyn®, Alleve® ɔ Motrin®) , ɔ ɔt ɛn kol tritmɛnt. Nɛv pen kin tranga fɔ trit. Sɔm mɛrɛsin wae de mek pɔrsin nɔr gɛt pwɛl hat ɔr kin ɛp.
• Mental hεlth mεnejmεnt: Pwεl hat sik kin kכmכn pan pipul dεm wae gεt TM. If yu gɛt sayn dɛm fɔ pwɛl hat ɔr ɔda kayn mɛntɛl hεlth, e fayn fɔ go to dɔktɔ ɔr sayɛnsman. Mɛrɛsin kin ɛp bak fɔ mɛn pwɛl hat.

Yu tink se dɛn kin mɛn transvas maylaytis?

Yɛs, dɛn kin mɛn transvas maylaytis (TM). Bɔt di we aw pɔsin kin wɛl kin difrɛn frɔm wan pɔsin to ɔda pɔsin.

Di hiling frɔm TM kin bi kɔmplit, pat, ɔ nɔ de. Bɔrku tɛm fɔ wɛl kin bigin insay wan to tri mɔnt frɔm di fɔs tritmɛnt. Bɔrku pipul kin wɛl frɔm TM insay tri mɔnt. Fɔ sɔm, i kin tek sɔm mɔnt ɔ ivin sɔm ia fɔ mek dɛn wɛl.

Sɔm pipul dɛn kin wɛl frɔm at at sik wit smɔl ɔ nɔr kin gɛt lɔng tɛm kɔmplikeshɔn, ɔda wan dɛn kin wɛl wit mɔdaret ɔr siriɔs disabled.

Pipul wae kin gɛt ridyus chans fɔ wɛl na:

• Dɛn wan wae gɛt dis sik kin bigin kwik kwik wan .
• Dɛn wan wae dɛn sik nɔr dɔn bɛtɛ insay di fɔs tri to siks mɔnt wae dɛn dɔn trit dɛn ɛn wɛl.

Wetin na di prɔgnosis fɔ transvas maylaytis (TM)?

Di luk/prognosis fɔ pipul dɛm wae gɛt transvas maylaytis kin difrɛn:

• Na lɛk 33% pan pipul dɛm kin wɛl wit smɔl ɔ nɔr kin gɛt lɔng tɛm kɔmplikeshɔn.
• Na lɛk 33% pan pipul dɛm kin wɛl wit mɔdaret disabiliti, lɛk fɔ gɛt prɔblɛm wit dɛn bɔdi ɛn i nɔ kin izi fɔ waka.
• Na lɛk 33% pan pipul dɛm kin wɛl wit pɔrmɛnt disabiliti, lɛk paralayz.

Bɔrku pipul kin gɛt transvas maylaytis wan tɛm nɔmɔ. Bɔt sɔm pipul dɛm wae gɛt wan ɔndalayn kɔndishɔn, lɛk multiple sclerosis (MS), kin mek i kam bak (`(recur)`). If yu gɛt TM we de afɛkt wan say nɔmɔ na yu bɔdi, yu kin gɛt MS tumara bambay.

Aw a go tek kia ɔf misɛf, ɔ pɔsin we gɛt transvas maylaytis (TM)?

If yu gɛt transvas maylaytis, i impɔtant fɔ mek shɔ se yu de gɛt di rayt mɛrɛsin fɔ mek yu nɔ gɛt ɔ trit TM kɔmplikeshɔn dɛn, lɛk prɔblɛm wit yu bɔdi ɛn blad ɛn fɔ mek yu mɔsul dɛn stif.Yu kin tink bak bɔt fɔ jɔyn sɔpɔt grup fɔ mit ɔda pipul dɛn we go ebul fɔ no wetin yu dɔn ɛkspiriɛns. Dɔn bak, if yu de fil pwɛl hat ɔr de wɔri bikɔs ɔf TM, i impɔtant fɔ aks fɔ ɛp frɔm dɔktɔ ɔr saikɔlɔjis.

If yu de kia fɔ pɔsin we gɛt TM, i impɔtant fɔ mek yu advatayz fɔ mek shɔ se dɛn gɛt di bɛst mɛrɛsin, divays fɔ muv, ɛn tritmɛnt dɛn we go ɛp dɛn fɔ bi mɔ indipɛndɛnt.

I kin tranga fɔ yu ɛn yu famili fɔ ajɔst to di tin dɛn we TM kin du to yu maynd ɛn bɔdi. We yu bigin fɔ wɛl, i impɔtant fɔ tich yu famili ɛn mek wan plan fɔ dil wit di prɔblɛm dɛn we de mit yu fɔ gɛt indipɛndɛns.

Ustɛm a fɔ go to dɔktɔ bɔt transvas maylaytis (TM)?

If yu gɛt sɔm sayn dɛn we de sho se yu gɛt transvas maylaytis, lɛk we yu mɔsul dɛn wik wantɛm wantɛm ɛn we yu de fil pen, go na di ɔspitul we de nia yu kwik kwik wan .

If dɛn dɔn no se yu gɛt TM, yu fɔ mit wit yu mɛdikal tim ɔltɛm fɔ gɛt tritmɛnt ɛn fɔ wach fɔ di prɔblɛm dɛn we kin apin.

Fɔ ɔndastand aw yu ɔ yu pɔsin we yu lɛk gɛt transvas maylaytis (TM) kin tranga. Bɔt yu mɛdikal tim go gi yu wan strɔng tritmɛnt ɛn rihabiliteshɔn plan we dɛn mek fɔ yu ɔ di pɔsin we yu lɛk in sik. E fayn fɔ mek shɔ se yu gɛt di lɔv ɛn sɔpɔt we yu nid ɔl di tɛm we yu de travul fɔ wɛl, ɛn fɔ de wach fɔ ɛni nyu sik we go kam.

Di tin dɛn we impɔtant pas ɔl fɔ mɛmba (Take-Home Message) .

Okay, so naw yu gɛt bɛtɛ aidia bɔt wetin na transvas maylaytis (TM). Mɛmba se pan ɔl we na sik we nɔ kin apin so ɔltɛm, i rili impɔtant fɔ go to dɔktɔ wantɛm wantɛm if yu gɛt sɔm sayn dɛn.

Di men tin na dat, if yu gɛt wikɛd tin wantɛm wantɛm, yu nɔ de fil fayn, ɔ yu gɛt prɔblɛm wit yu urinary control, nɔ ignore am. Go to dɔktɔ wantɛm wantɛm.

TM kin gɛt bɔku tin dɛn we kin mek i apin, ɛn sɔntɛnde dɛn nɔ kin fɛn ɛni kɔz. Bɔt if dɛn gɛt di rayt tritmɛnt ɛn rihabiliteshɔn, bɔku pipul dɛn kin ebul fɔ gɛt sɔm lɛvul fɔ wɛl. Sɔm pipul dɛn kin wɛl kpatakpata.

Wae yu de liv wit dis kayn sik, e fayn fɔ mek yu gɛt strɔng maynd ɛn fɔ gɛt sɔpɔt frɔm yu famili ɛn dɔktɔ dɛm. So, nɔ fred fɔ tɔk to yu dɔktɔ bɔt ɛnitin we de mɔna yu.

` Transvas maylaytis, TM, spεnal kכd, nyuropati, inflameshn, maylin, simptom dεm, tritmεnt